Skip to main content
Clinical Trials/NCT01103479
NCT01103479CompletedPhase 2

Low-Literacy Physician-Patient Intervention Promoting Colorectal Cancer Screening

Northwestern University2 sites in 1 country569 target enrollmentStarted: April 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
569
Locations
2
Primary Endpoint
Colorectal Cancer (CRC) Screening Completion

Study Overview

Brief Summary

The purpose of this study is to evaluate the effectiveness of a low literacy, physician and patient-directed intervention to promote colorectal cancer (CRC) screening among the medically underserved.

Detailed Description

This study will test the separate and combined effect of two of these interventions: 1) a provider communication skills training using a continuous quality improvement (CQI) framework, and 2) a brief, multimedia Patient Education Program (PEP) that incorporates plain language, graphic design, and audio voice-over to overcome literacy limitations. Our provider intervention has demonstrated efficacy to significantly improve CRC screening recommendation rates. Our multimedia program has also been field tested among patients with limited literacy and was able to improve patient knowledge and intention to receive screening.

We will implement both provider-only and combined provider-patient strategies within a federally qualified health center network to determine the most effective and efficient approach to promote CRC screening in these settings. Results from the study, supplemented by cost analyses and the process evaluation will directly inform translational strategies for cancer prevention within difficult community-based healthcare settings.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Participant)

Eligibility Criteria

Ages
50 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients aged 50-75 years of age (in month 1 of the study)
  • •Patients have had two or more visits to the clinic during the past two years
  • •ACCESS Community Health Network patients
  • •University of Illinois Hospital & Health Sciences System patients
  • •Patients ages 50 - 75 as of the start of the intervention study
  • •English or Spanish-Speaking

Exclusion Criteria

  • •Patients <50 or > 75 years of age
  • •Patients who have had fewer than two or more visits to the clinic during the past two years
  • •Personal history of CRC or colorectal polyps, or of inflammatory bowel disease and a family history with a first-degree relative with CRC or colorectal polyps.
  • •Unable to speak English or Spanish
  • •Compliant with CRC screening (FOBT or FIT within the past year; flexible sigmoidoscopy within past 5 years; colonoscopy within past 10 years)

Arms & Interventions

Control

No Intervention

Participants will complete interviewer-administered pre- and post-test

Physician Intervention

Experimental

Physicians at these clinics will participate in 6 training sessions over the course of 3 1/2 years; training sessions relate to colorectal cancer screening guidelines, communication skills, and health literacy training

Intervention: Physician Intervention (Behavioral)

Physician and Patient Intervention

Experimental

Physicians at these clinics will participate in 6 training sessions over the course of 3 1/2 years; training sessions relate to colorectal cancer (CRC) screening guidelines, communication skills, and health literacy training; patients in this condition will also view an educational digital video disc (DVD) on CRC and CRC screening

Intervention: Physician and Patient Intervention (Behavioral)

Outcomes

Primary Outcomes

Colorectal Cancer (CRC) Screening Completion

Time Frame: within 6 months of provider recommendation

CRC screening completion via Fecal Occult Blood Test (FOBT), Fecal Immunochemical Test (FIT) or Colonoscopy

Secondary Outcomes

  • Provider Recommendation of CRC Screening(6 months following patient enrollment into study)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kenzie Cameron

Research Associate Professor

Northwestern University

Study Sites (2)

Loading locations...

Similar Trials